24/7 Patient Assistance: 760-405-8205
specialties & services
Dr. Dmitriy Zak is a well-known medical oncologist in Tuscaloosa, Alabama. He earned his medical degree from Tashkent State Medical Institute and went to Lutheran Medical Center where he completed his residency in Internal Medicine. Furthermore, Dr. Dmitriy Zak did a fellowship in Hematology and Medical Oncology at Drexel University Hospital in Philadelphia. After completing his medical studies and training, Dr. Zak got certified by the American Board in Medical Oncology, Hematology, and Internal Medicine. Dr. Zak is currently working at two clinics, one of them is Cancer Care Center of Tuscaloosa and is also affiliated with 5 hospitals including Baptist Medical Center East and DCH Regional Medical Center. With a vast experience of over 20 years in the medical oncology field, Dr. Dmitriy Zak helps several patients improve their quality of life after they’ve been diagnosed with mesothelioma or lung cancer.
AetnaAetna Choice POS IIAetna HMOBlue Cross of CaliforniaBlue Shield of CaliforniaCignaFirst Health PPOHumanaMedicaidMultiPlanTRICAREUnited Healthcare
Interviews with Dmitriy Zak
About Dimitry Zak - Oncologist/Hematologist
Dimitry Zak - Improving Quality of life for Mesothelioma and Lung Cancer Patients
Dimitry Zak - Reasons to get treatment as a Mesothelioma or Advanaged Lung Cancer patient
Lutheran Medical Center
Residency
Second Tashkent State Medical Institute
Medical School
Drexel University - Hahnemann University Hospital
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
DCH Regional Medical Center
Languages: English/Spanish
(205) 759-7111
809 University Blvd E
Read MorePrinceton Baptist Medical Center
Languages: English/Spanish
(205) 783-3000
701 Princeton Ave SW
Read MoreCancer Care Center of Tuscaloosa
Languages: English/Spanish
(205) 345-8208
1410 McFarland Blvd North
Read MoreNorthwest Regional Cancer Center
Languages: English/Spanish
(205) 487-4405
171 Carraway Dr.
Read MoreCombination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma
Dmitry Zak, Michael J Styler, Jonathan Z Rosenbluth, Isadore Brodsky: Article · May 2005 · Clinical advances in hematology & oncology: H&O
See more >>